Invivyd announces 12-month exploratory data from CANOPY Phase 3 trial
PremiumThe FlyInvivyd announces 12-month exploratory data from CANOPY Phase 3 trial
12d ago
Invivyd announces FDA update on Pemgarda fact sheet for SARS-CoV-2 variants
Premium
The Fly
Invivyd announces FDA update on Pemgarda fact sheet for SARS-CoV-2 variants
1M ago
Invivyd provides virology data, analysis of SARS-CoV-2 structural biology
Premium
The Fly
Invivyd provides virology data, analysis of SARS-CoV-2 structural biology
2M ago
Mars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
PremiumThe FlyMars buys Kellanova, Cardinal Health reports Q4 beat: Morning Buzz
3M ago
Invivyd reports Q2 EPS (40c), consensus (37c)
Premium
The Fly
Invivyd reports Q2 EPS (40c), consensus (37c)
3M ago
Invivyd announces addition to Russell 2000, Russell 3000 Indexes
Premium
The Fly
Invivyd announces addition to Russell 2000, Russell 3000 Indexes
4M ago
Invivyd elects two new independent members to board of directors
PremiumThe FlyInvivyd elects two new independent members to board of directors
6M ago
Invivyd reports Q1 EPS (38c), consensus (47c)
Premium
The Fly
Invivyd reports Q1 EPS (38c), consensus (47c)
6M ago
Invivyd to submit EUA to FDA for treatment of mild to moderate COVID-19
Premium
The Fly
Invivyd to submit EUA to FDA for treatment of mild to moderate COVID-19
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100